Studies on the Expression of the Deleted KIR2DS4*003 Gene Product and Distribution of KIR2DS4 Deleted and Nondeleted Versions in Different Populations

Human Immunology

Volumn 68, Issue 2, 2007, Pages 128-134

  Middleton, Derek ^a,b   Gonzalez, Asensio ^a   Gilmore, Paula M ^a  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

KIR2DS4 deletion variant; novel carboxyl end; population frequencies; secreted KIR molecule

Indexed keywords

GENE PRODUCT; KILLER IMMUNOGLOBULIN LIKE RECEPTOR; PROTEIN KIR2DS4; RECEPTOR; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; EXON; FRAMESHIFT MUTATION; GENE; GENE ACTIVATION; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INCIDENCE; KIR2DS4 GENE; NONHUMAN; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN SECRETION; UNITED KINGDOM;

ANIMALS; BRAZIL; CERCOPITHECUS AETHIOPS; COS CELLS; CUBA; FINLAND; GENE DELETION; GENE FREQUENCY; HONG KONG; HUMANS; KILLER CELLS, NATURAL; MEXICO; OMAN; RECEPTORS, IMMUNOLOGIC; SINGAPORE; SOLUBILITY; SOUTH AFRICA; SPAIN;

EID: 33847140709     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2006.12.007     Document Type: Article

References (38)

1. Taylor L.S., Paul S.P., and McVicar D.W. Paired inhibitory and activating receptor signals. Rev Immunogenet 2 (2000) 204
2. Lanier L.L. NK cell receptors. Annu Rev Immunol 16 (1998) 359
3. Moretta L., Biassoni R., Bottino C., Mingari M.C., and Moretta A. Human NK-cell receptors. Immunol Today 9 (2000) 420
4. Trowsdale J. Genetic and functional relationships between MHC and NK receptor genes. Immunity 3 (2001) 363
5. Vilches C., and Parham P. KIR: Diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 20 (2002) 217
6. Borrego F., Kabat J., Kim D.K., Lieto L., Maasho K., Pena J., Solana R., and Coligan J.E. Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells. Mol Immunol 38 (2002) 637
7. Wende H., Colonna M., Ziegler A., and Volz A. Organisation of the leukocyte receptor cluster (LRC) on human Chromosome 19q13.4. Mamm Genome 10 (1999) 154
8. Martin A.M., Freitas E.M., Witt C.S., and Christiansen F.T. The genomic organisation and evolution of the natural killer immunoglobulin-like receptor (KIR) gene cluster. Immunogenetics 51 (2000) 268
9. Wilson M.J., Torkar M., Haude A., Milne S., Jones T., Sheer D., Beck S., and Trowsdale J. Plasticity in the organisation and sequences of human KIR/ILT gene families. Proc Natl Acad Sci USA 97 (2000) 4778
10. Boyington J.C., Motyka S.A., Schuck P., Brooks A.G., and Sun P.D. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 405 (2000) 537
11. Fan Q.R., Long E.O., and Wiley D.C. Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat Immunol 2 (2001) 452
12. Uhrberg M., Valiante N.M., Shum B.P., Shilling H.G., Leinert-Weidenbach K., Corliss B., Tyan D., Lanier L.L., and Parham P. Human diversity in killer cell inhibitory receptor genes. Immunity 7 (1997) 753
13. Witt C.S., Dewing C., Sayer D.C., Uhrberg M., Parham P., and Christiansen F.T. Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination. Transplantation 68 (1999) 1784
14. Crum K.A., Logue S.E., Curran M.D., and Middleton D. Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires. Tissue Antigens 56 (2000) 313
15. Norman P.J., Stephens H.A., Verity D.H., Chandanayingyong D., and Vaughan R.W. Distribution of natural killer cell immunoglobulin-like receptor sequences in three ethnic groups. Immunogenetics 52 (2001) 195
16. Toneva M., Lepage V., Lafay G., Dulphy N., Busson M., Lester S., Vu-Trien A., Michaylova A., Naumova E., McCluskey J., and Charron D. Genomic diversity of natural killer cell receptor genes in three populations. Tissue Antigens 57 (2001) 358
17. Steffens U., Vyas Y., Dupont B., and Selvakumar A. Nucleotide and amino acid sequence alignment for human killer cell inhibitory receptors (KIR), 1998. Tissue Antigens 51 (1998) 398
18. Colonna M., Borsellino G., Falco M., Ferrara G.B., and Strominger J.L. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1-and NK2-specific natural killer cells. Proc Natl Acad Sci USA 90 (1993) 12000
19. Katz G., Markel G., Mizrahi S., Arnon T.I., and Mandelboim O. Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 4. J Immunol 166 (2001) 7260
20. Katz G., Gazit R., Arnon T.I., Gonen-Cross T., Tarcic G., Markel G., Gruda R., Achdout H., Dreize O., Merims S., and Mandelboim O. MHC class I-independent recognition of NK-activating receptor KIR2DS4. J Immunol 173 (2004) 1819
21. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 5 (2005) 201
22. Middleton D., Curran M.D., and Maxwell L. Natural killer cells and their receptors. Transpl Immunol 10 (2002) 147
23. Middleton D., Williams F., and Halfpenny I.A. KIR genes. Transpl Immunol 14 (2005) 135
24. Hsu K.C., Liu X.-R., Selvakumar A., Mickelson E., O'Reilly R.J., and Dupont B. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol 169 (2002) 5118
25. Maxwell L.D., Wallace A., Middleton D., and Curran M. A common KIR2DS4 deletion variant in the human that predicts soluble KIR molecule analogous to the KIR1D molecule observed in the rhesus monkey. Tissue Antigens 60 (2002) 254
26. Maxwell L.D., Williams F., Gilmore P., Meenagh A., and Middleton D. Investigation of killer cell immunoglobulin-like receptor gene diversity: II. KIR2DS4. Hum Immunol 65 (2004) 613
27. Colonna M., Navarro F., Bellin T., Llano M., Garcia P., Samaridis J., Angman L., Cella M., and Lopez-Botet M. A common inhibitory receptor for major histocopatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 186 (1997) 1809
28. Borges L., Hsu M.L., Fanger N., Kubin M., and Cosman D. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J Immunol 159 (1997) 5192
29. Arm J.P., Nwanko C., and Austen K.F. Molecular identification of a novel family of human Ig superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp-49B1 inhibitory receptor. J Immunol 159 (1997) 2342
30. Meyaard L., Adema G.J., Chang C., Woollatt E., Sutherland G.R., Lanier L.L., and Phillips J.H. LAIR-1, a novel inhibitory receptor expressed on human mononuclear leucocytes. Immunity 7 (1997) 283
31. Gomez-Lozano N., Estefania E., Williams F., Halfpenny I., Middleton D., Solis R., and Vilches C. The silent KIR3DP1 gene (CD158C) is transcribed and might encode a secreted receptor in a minority of humans, in whom the KIR3DP1, KIR2DL4 and KIR3DL1/KIR3DS1 genes are duplicated. Eur J Immunol 35 (2005) 16
32. Yawata M., Yawata N., Draghi M., Little A.M., Partheniou F., and Parham P. Roles for HLA and KIR polymorhisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med 203 (2006) 633
33. Parham P. Immunogenetics of killer-cell immunoglobulin-like receptors. Tissue Antigens 62 (2003) 194
34. Toneva M., Lepage V., Lafay G., Dulphy N., Busson M., Lester S., Vu-Trien A., Michaylova A., Naumova E., McCluskey J., and Charron D. Genomic diversity of natural killer cell receptor genes in three populations. Tissue Antigens 57 (2001) 358
35. Whang D.H., Park H., Al Yoon J., and Park M.H. Haplotype analysis of killer cell immunoglobulin-like receptor genes in 77 Korean families. Hum Immunol 66 (2005) 146
36. Moretta L., Bottino C., Pende D., Vitale M., Mingari M.C., and Moretta A. Different checkpoints in human NK-cell activation. Trends Immunol 25 (2004) 670
37. Hiby S.E., Walker J.J., O'Shaughnessy K.M., Redman C.W., Carrington M., Trowsdale J., and Moffett A. Combination of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 200 (2004) 957
38. Denis L., Sivula J., Gourraud P.A., Kerdudou N., Chout R., Ricard C., Moisan J.P., Gagne K., Partanen J., and Bignon J.D. Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and Reunion. Tissue Antigens 66 (2005) 267